SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-17-010243
Filing Date
2017-02-17
Accepted
2017-02-17 17:16:04
Documents
1
Group Members
DAVID SCHIFFIMMY FUNDING LLCLIFE SCIENCES ALTERNATIVE FUNDING HOLDINGS LLCLSAF FUNDING LLCLSAF HOLDINGS LLCPERELLA WEINBERG PARTNERS ASSET BASED VALUE GP L. P.PERELLA WEINBERG PARTNERS ASSET BASED VALUE GP LLCPERELLA WEINBERG PARTNERS ASSET BASED VALUE MA

Document Format Files

Seq Description Document Type Size
1 SC 13G a16-23885_1sc13ga.htm SC 13G/A 263022
  Complete submission text file 0001104659-17-010243.txt   265132
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83793 | Film No.: 17622342
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVENUE NEW YORK NY 10153
Business Address 767 FIFTH AVENUE NEW YORK NY 10153 212-287-3200
Perella Weinberg Partners Capital Management LP (Filed by) CIK: 0001426083 (see all company filings)

IRS No.: 208547180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A